Assignee
CLEMENTIA PHARMACEUTICALS INC
CA·6 granted patents·3 pending applications·13 citations·filing 2016–2025
Top patents by PatentIndex Score
9 records- 0192US11622959B2Methods for treating heterotopic ossificationCLEMENTIA PHARMACEUTICALS INC·Filed 2020·Granted Apr 11, 2023·4 cites·18 claims
- 0290US12201614B2Methods for treating heterotopic ossificationCLEMENTIA PHARMACEUTICALS INC·Filed 2024·Granted Jan 21, 2025·1 cites·30 claims
- 0389US12138245B2Methods for treating heterotopic ossificationCLEMENTIA PHARMACEUTICALS INC·Filed 2024·Granted Nov 12, 2024·1 cites·18 claims
- 0487US10864194B2Methods for treating heterotopic ossificationCLEMENTIA PHARMACEUTICALS INC·Filed 2017·Granted Dec 15, 2020·7 cites·30 claims
- 0582US12458626B2Methods for treating heterotopic ossificationCLEMENTIA PHARMACEUTICALS INC·Filed 2023·Granted Nov 4, 2025·0 cites·24 claims
- 0681US2026021073A1Methods for treating heterotopic ossificationCLEMENTIA PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0751US2022054487A1Methods for treating heterotopic ossificationCLEMENTIA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0846US10980778B2Methods for treating multiple osteochondroma (MO)CLEMENTIA PHARMACEUTICALS INC·Filed 2017·Granted Apr 20, 2021·0 cites·23 claims
- 0940US2017159056A1Antisense oligonucleotides and methods of use thereofCLEMENTIA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CLEMENTIA PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →